17α-Hydroxyprogesterone (17-OHP) is an endogenous progestogen produced during the biosynthesis of glucocorticoids and sex steroids. It serves as the core diagnostic marker for Congenital Adrenal Hyperplasia (CAH).

AccuSift provides high-performance competitive antibody pairs for 17α-hydroxyprogesterone detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.